Table of Contents
ISRN Addiction
Volume 2013, Article ID 450348, 6 pages
http://dx.doi.org/10.1155/2013/450348
Review Article

The Destructive Capacity of Drug Abuse: An Overview Exploring the Harmful Potential of Drug Abuse Both to the Individual and to Society

King’s College Hospital London, NHS Foundation Trust, London SE5 9RS, UK

Received 13 May 2013; Accepted 6 June 2013

Academic Editors: X. Liu, S. Rahman, and Y. Ye

Copyright © 2013 Thomas Peter Fox et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Nutt, L. A. King, W. Saulsbury, and C. Blakemore, “Development of a rational scale to assess the harm of drugs of potential misuse,” The Lancet, vol. 369, no. 9566, pp. 1047–1053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Trozak and W. M. Gould, “Cocaine abuse and connective tissue disease,” Journal of the American Academy of Dermatology, vol. 10, no. 3, p. 525, 1984. View at Google Scholar · View at Scopus
  3. A. N. Westover, S. McBride, and R. W. Haley, “Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients,” Archives of General Psychiatry, vol. 64, no. 4, pp. 495–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. http://www.toxbase.org/.
  5. N. R. Carlson, Physiological Psychology, Pearson, London, UK, 6th edition, 1996.
  6. R. Doll, R. Peto, J. Boreham, and I. Sutherland, “Mortality in relation to smoking: 50 Years' observations on male British doctors,” British Medical Journal, vol. 328, no. 7455, pp. 1519–1528, 2004. View at Google Scholar · View at Scopus
  7. “Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP,” British Association for Psychopharmacology, May 2012.
  8. Health Protection Agency, “Shooting Up: infections among injecting drug users in the United Kingdom 2006,” Health Protection Agency, London, UK, 2007.
  9. M. Frischer, D. Goldberg, M. Rahman, and L. Berney, “Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994,” Addiction, vol. 92, no. 4, pp. 419–427, 1997. View at Google Scholar · View at Scopus
  10. L. Pagliaro and A. M. Pagliaro, “Pagliaros comprehensive guide to drugs and substances of abuse,” The American Journal of Psychiatry, vol. 161, pp. 2148–2149, 2004. View at Google Scholar
  11. M. F. Baigent, “Physical complications of substance abuse: what the psychiatrist needs to know,” Current Opinion in Psychiatry, vol. 16, no. 3, pp. 291–296, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Fieldman, S. Jerrold, and L. Quenzer, Principles of Neuropsychopharmocology, Sinauer Associates, Sunderland, Mass, USA, 1997.
  13. A. E. Evins, A. I. Green, J. M. Kane, and R. M. Murray, “Does using marijuana increase the risk for developing schizophrenia?” Journal of Clinical Psychiatry, vol. 74, article e08, no. 4, 2013. View at Google Scholar
  14. http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs/health-effects.
  15. D. J. Trozak and W. M. Gould, “Cocaine abuse and connective tissue disease,” Journal of the American Academy of Dermatology, vol. 10, no. 3, p. 525, 1984. View at Google Scholar · View at Scopus
  16. P. M. Moore and B. Richardson, “Neurology of the vasculitides and connective tissue diseases,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 65, no. 1, pp. 10–22, 1998. View at Google Scholar
  17. P. Ramón, R. A. Navascués, J. Baltar, M. Seco, and J. Alvarez, “Antiglomerular basement membrane antibody-mediated glomerulonephritis after intranasal cocaine use,” Nephron, vol. 81, no. 4, pp. 434–438, 1999. View at Google Scholar · View at Scopus
  18. A. N. Westover, S. McBride, and R. W. Haley, “Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients,” Archives of General Psychiatry, vol. 64, no. 4, pp. 495–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Vasica and C. C. Tennant, “Cocaine use and cardiovascular complications,” Medical Journal of Australia, vol. 177, no. 5, pp. 260–262, 2002. View at Google Scholar · View at Scopus
  20. National Institute on Alcohol Abuse and Alcoholism, “Brian centres involved in reward,” 2007, http://pubs.niaaa.nih.gov/.
  21. D. Grilly, Drugs and Human Behaviour, Pearson, London, UK, 5th edition, 2006.
  22. C. P. O'Brien, A. R. Childress, A. T. McLellan, and R. Ehrman, “Developing treatments that address classical conditioning,” NIDA Research Monograph Series, no. 135, pp. 71–91, 1993. View at Google Scholar · View at Scopus
  23. G. F. Koob, “Drug addiction: the Yin and Yang of hedonic homeostasis,” Neuron, vol. 16, no. 5, pp. 893–896, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Saah, “The evolutionary origins and significance of drug addiction,” Harm Reduction Journal, vol. 2, article 8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Nesse and K. C. Berridge, “Psychoactive drug use in evolutionary perspective,” Science, vol. 278, no. 5335, pp. 63–66, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. S. King, “Substance abuse disorders: neurocircuitry and neurobiology,” Module SBM 302, 2009, https://www.studentcentral.brighton.ac.uk/.
  27. D. I. Lubman, M. Yücel, J. W. Kettle et al., “Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use,” Archives of General Psychiatry, vol. 66, no. 2, pp. 205–212, 2009. View at Publisher · View at Google Scholar
  28. N. D. Volkow and T.-K. Li, “Drug addiction: the neurobiology of behaviour gone awry,” Nature Reviews Neuroscience, vol. 5, no. 12, pp. 963–970, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. King, “Reward and addictive behaviours,” Module 202, 2008, https://www.studentcentral.brighton.ac.uk/.
  30. N. Carlson, Foundations of Physiological Psychology, Pearson, London, UK, 6th edition, 2005.
  31. J. S. Jorquez, “Heroin use in the Barrio: solving the problem of relapse or keeping the Tecato Gusano asleep,” American Journal of Drug and Alcohol Abuse, vol. 10, no. 1, pp. 63–75, 1984. View at Google Scholar · View at Scopus
  32. B. Marsh, “The cycle of rehabilitation and relapse among heroin addicts,” Social Problems, vol. 9, no. 2, pp. 132–140, 1961. View at Publisher · View at Google Scholar
  33. S. Stahl, Essential Psychopharmocology, Cambridge University Press, Cambridge, UK, 2nd edition, 2002.
  34. T. R. Franklin, P. D. Acton, J. A. Maldjian et al., “Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients,” Biological Psychiatry, vol. 51, no. 2, pp. 134–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Fotros, K. F. Casey, K. Larcher et al., “Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [18F] fallypride study in cocaine dependent participants,” Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  36. T. F. Borders, B. M. Booth, R. S. Falck, C. Leukefeld, J. Wang, and R. G. Carlson, “Longitudinal changes in drug use severity and physical health-related quality of life among untreated stimulant users,” Addictive Behaviors, vol. 34, no. 11, pp. 959–964, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. ACMD, Hidden Harm: Responding to the Needs of Children of Problem Drug Users, Advisory Council for the Misuse of Drugs, London, UK, 2003.
  38. K. M. Kuczkowski, “Cocaine abuse in pregnancy—anesthetic implications,” International Journal of Obstetric Anesthesia, vol. 11, no. 3, pp. 204–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. “The National Survey on Drug Use and Health,” 2010, https://nsduhweb.rti.org/.
  40. D. A. Bateman and C. A. Chiriboga, “Dose-response effect of cocaine on newborn head circumference,” Pediatrics, vol. 106, no. 3, supplement E33, 2000. View at Google Scholar · View at Scopus
  41. PhyOrg.com, “Prenatal cocaine exposure impairs infants' response to stress,” 2009, http://phys.org/news151690493.html.
  42. J. P. Ackerman, T. Riggins, and M. M. Black, “A review of the effects of prenatal cocaine exposure among school-aged children,” Pediatrics, vol. 125, no. 3, pp. 554–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Pinel, Biopsychology, Pearson, London, UK, 6th edition, 2006.
  44. National Drug Intelligence Center, 2006, http://www.justice.gov/archive/ndic/.
  45. D. M. Reilly, “Drug-abusing families: intrafamilial dynamics and brief triphasic treatment,” in Family Therapy of Drug and Alcohol Abuse, E. Kaufman and P. Kaufmann, Eds., pp. 105–119, Allyn and Bacon, Boston, Mass, USA, 2nd edition, 1992. View at Google Scholar
  46. J. Pinel, Biopsychology, Pearson, London, UK, 6th edition, 2006.
  47. L. Gordon, L. Tinsley, C. Godfrey, and S. Parrott, “The economic and social costs of class A drug use in England and Wales, 2003/04 (Measuring different aspects of problem drug use: methodological developments),” Home Office Online Report 16/06, chapter 3, 2006. View at Google Scholar